Senior Editor – Europe
Latest From David Ridley
Haleon’s Puraflor probiotic when taken daily by adults was shown to alter gray matter volume and brain response patterns, according to a study published in the journal Cells.
Bayer UK sees the recent launch of Berocca Immuno as a step towards "mega-brand" status for its line of effervescent VMS tablets.
Two new RCTs cast further doubt on the preventative effects of vitamin D supplementation with regards to COVID-19 infection. Nevertheless, an editorial in the British Medical Journal, where the studies were published, leaves open positive effects for those suffering from vitamin D deficiency, and recommends a daily supplement of up to 2000IU just in case.
A novel strain of the popular lactiplantibacillus plantarum probiotic species has delivered promising results in in a recent clinical trial exploring its use in weight management.
Health literacy and natural alternatives are two areas where Haleon's EMEA and LATAM head Filippo Lanzi sees potential for growth, in addition to Rx-to-OTC switch, he tells HBW Insight in an exclusive interview. Lanzi also digs deeper into Haleon's recently published first-half sales and earnings results and shares his thoughts on how the firm will meet the multiple challenges posed by the current social and economic environment.
Despite growing by over 10% in the first six months of this year, sales of self-care products through German bricks-and-mortar pharmacy have not returned to 2020 levels. Conversely, the mail order channel continues to grow as consumers shop from home.